Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: an observational prospective study | Zendy

AI Assistant Blog Pricing

Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: an observational prospective study

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.